Navigation Links
USC Norris cancer research ranks among top clinical advances for 2012
Date:12/5/2012

USC Norris Comprehensive Cancer Center research that identifies specific genes that have to be turned off in order for cancer cells to survive was named one of the top major advances in cancer research this year by the American Society of Clinical Oncology (ASCO).

The study, "DNA methylation screening identifies driver epigenetic events of cancer cell survival," first appeared in the May 15 issue of Cancer Cell, a peer-reviewed scientific journal. It is one of 87 studies highlighted in Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, available online in the Journal of Clinical Oncology at http://www.jco.org.

The annual report, now in its eighth year, is an independent review of clinical cancer research advances that have the greatest potential to improve patients' survival and quality of life. Compiled and edited under the guidance of 21 renowned experts in specific fields of cancer research, the report describes, in lay language, the most significant advances of the year, offering the public a window into the achievements, trends and challenges in oncology.

The USC study, which appears in the tumor biology section of the report, was led by Peter Jones, Ph.D., D.Sc., distinguished professor of urology, biochemistry and molecular biology at the Keck School of Medicine of USC.

"We want to know what makes a cancer cell a cancer cell," said Jones, an epigenetics pioneer who discovered the mechanism behind the drug 5-azacytidine, which is now standard treatment for a pre-leukemia bone-marrow disorder. "This particular study was the first to track down these genes that, when silenced through DNA methylation, allow the cancer cell to avoid normal death."

DNA methylation, or the addition of methyl groups to a gene, can change gene expression without changing the DNA sequence. This epigenetic process is potentially reversible, making the areas where it happens good targets for new treatments to be developed.

"Our findings essentially pave the way for more effective cancer medicine," said the study's first author, Daniel D. De Carvalho, Ph.D., a USC post-doctoral fellow who now leads a lab at the Ontario Cancer Institute at Princess Margaret Cancer Centre in Toronto. "Our research continues to focus on understanding the epigenetic mechanisms that underlie how tumors are created in order to develop new and more efficient cancer treatments."


'/>"/>

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences
Source:Eurekalert

Related medicine news :

1. African American women with breast cancer less likely to have newer, recommended surgical procedure
2. Mayo Clinic: Less invasive surgery detects residual breast cancer in lymph nodes after chemotherapy
3. Racial Disparities Still Seen in Use of Breast Cancer Treatments
4. New Drug Regimens May Slow Advanced Breast Cancer
5. Breath test could possibly diagnose colorectal cancer
6. UNM Cancer Center researchers study new target for breast cancer
7. Longer life expectancy, aging population necessitate new strategies for prostate cancer care
8. UK initiates first cancer reporting model of its kind in US
9. Drug shows promise in prostate cancer spread to bone
10. Genetic data shows that skin cancer risk includes more than UV exposure
11. Unexpected toughness may mark out cancer cells in the blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... 2017 , ... Gastro Health (“GH”) ( http://www.gastrohealth.com ) ... colonoscopy at the HyGIeaCare® Center that is to be located adjacent to the ... The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration (FDA), will ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased ... Building 2. The clinic is the group’s second in New Braunfels and 22nd in ... second New Braunfels location brings things full circle for the group, “It’s crazy to ...
(Date:3/23/2017)... NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware of ... kids do not brush their teeth the minimum two times a day that dentists recommend. ... students missing 51 million hours of school and adults missing 164 million hours of work ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 CENTRO DE IMAGEM ... 157, paragraph 4 of Law 6,404/76 and Instruction 358/02 ... informs its shareholders and the market in general that ... subsidiary Centro de Diagnosticos por Imagem Ltda. (" CDI ... interest in RADIOLOGISTAS ASSOCIADOS LTDA. (" Partnership " and ...
(Date:3/23/2017)... 2017 Ascendis Pharma A/S (Nasdaq: ASND), a ... address significant unmet medical needs in rare diseases, today ... and webcast on Monday, April 3 during ENDO 2017, ... Orlando, Florida , to discuss new data ... Hormone, TransCon PTH and TransCon CNP). Ascendis ...
(Date:3/23/2017)... 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" ... MD announces that AB Laboratories Inc. ("AB Labs") has ... facility under the Access to Cannabis for Medical Purposes ... . The facility, which was licensed ... currently operating at half capacity, with full production capacity ...
Breaking Medicine Technology: